News Valneva SE Pref. Euronext Paris

Equities

VLAP

FR0011472943

Real-time Euronext Paris Other stock markets			5-day change	1st Jan Change
- ^EUR	-.--%		-7.89%	-28.57%

Jul. 01	Valneva's Secures Marketing Authorization in Europe for Chikungunya Vaccine	MT
Jul. 01	New semester, new state of mind

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Valneva Receives Marketing Authorization in Europe for the World's First Chikungunya Vaccine, IXCHIQ	Jul. 02	AQ
Valneva's Secures Marketing Authorization in Europe for Chikungunya Vaccine	Jul. 01	MT
New semester, new state of mind	Jul. 01
Valneva SE Receives Marketing Authorization in Europe for the World's First Chikungunya Vaccine, Ixchiq	Jul. 01	CI
Valneva: Marketing authorization granted to Ixchiq in Europe	Jul. 01	CF
Valneva Receives Marketing Authorization in Europe for the World’s First Chikungunya Vaccine, IXCHIQ®	Jul. 01	GL
Valneva's Chikungunya Vaccine Secures Approval for Use in EU	Jun. 28	MT
Valneva Announces Successful Outcome of its Combined General Meeting and Appointment of a New Director to its Board	Jun. 26	GL
Valneva SE Appoints Daniele Guyot-Caparros as Board of Directors	Jun. 26	CI
Valneva : 2023 Combined General Meeting – Presentation	Jun. 26	PU
Valneva's Chikungunya Vaccine Receives Health Canada's Approval	Jun. 24	MT
Valneva rises after Canadian approval for its chikungunya vaccine	Jun. 24	RE
Valneva Secures Canadian Approval for Chikungunya Vaccine	Jun. 24	MT
Europe opens hesitant as metal prices fall	Jun. 24	RE
Valneva: Ixchiq approved in Canada	Jun. 24	CF
Valneva Announces Health Canada Approval of the World’s First Chikungunya Vaccine, IXCHIQ®	Jun. 24	GL
Valneva : Announces Availability of Documentation for its Shareholder Meeting and Provides Corporate Update	Jun. 05	PU
Valneva Announces Availability of Documentation for its Combined Shareholder Meeting and Provides Corporate Update	Jun. 05	GL
Valneva to Present and Hold Investor Meetings at Upcoming Conferences in June	Jun. 04	GL
Pfizer: article on Lyme vaccine in The Lancet	Jun. 04	CF

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Valneva SE Pref. Euronext Paris

Equities

VLAP

FR0011472943

Summary

Filters